Benzinga | Nov 5, 2021 09:31AM EDT

Bellicum Pharmaceuticals Q3 EPS $0.07 Up From $(0.18) YoY

Bellicum Pharmaceuticals (NASDAQ:BLCM) reported quarterly earnings of $0.07 per share. This is a 138.89 percent increase over losses of $(0.18) per share from the same period last year.